NCT05131867View on ClinicalTrials.gov

Management of Cerebral Vascular Spasm in Posttraumatic Subarachnoid Hemorrhage Using Combination Therapy

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 24, 2021

Primary Completion Date

May 23, 2022

Study Completion Date

May 24, 2022

Conditions

Oral NimodipineMilrinoneVascular Spasm After Traumatic Subarachnoidhaemorrhage

Interventions

DRUG

nimodipine

(60 mg/4 hours) orally or via nasogastric tube

DRUG

Oral Nimodipine and milrinone

Oral Nimodipine then after the diagnosis of vasospasm is confirmed, start milrinone bolus

Trial Locations (2)

44519

Aculty of Medicine,Zagazig University, Zagazig

Faculty of Medicine,Zagazig University, Zagazig

All Listed Sponsors

lead

Zagazig University

OTHER_GOV

NCT05131867 - Management of Cerebral Vascular Spasm in Posttraumatic Subarachnoid Hemorrhage Using Combination Therapy | Biotech Hunter | Biotech Hunter